Web Version

Dear Researcher,

Nucleosome substrates are emerging tools for the in vitro study of chromatin epigenetic regulation, with applications from basic chromatin biology research to high-throughput drug screening.

NEW! Recombinant Nucleosomes

Our new partner EpiCypher has developed the largest portfolio of fully defined and homogeneous recombinant nucleosomes on the market that incorporate different DNA and histone modifications, site mutations and histone variants. The use of nucleosome substrates in drug discovery assays is a dramatic improvement over peptides, providing access to historically challenging targets.

BioCat GmbH

Im Neuenheimer Feld 584
D-69120 Heidelberg
Tel:  +49 (0) 6221 7141516
Fax: +49 (0) 6221 7141529
Email: info@biocat.com
Web: https://www.biocat.com